Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Boehringer Ingelheim
Mallinckrodt
Accenture
Deloitte

Generated: March 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ergonovine

« Back to Dashboard

US Patents for Ergonovine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ergonovine ➤ Sign Up Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues University of Utah (Salt Lake City, UT) ➤ Sign Up
Ergonovine ➤ Sign Up Compositions and methods of manufacture of compressed powder medicaments University of Utah Research Foundation (Salt Lake City, UT) ➤ Sign Up
Ergonovine ➤ Sign Up Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ACE inhibitor E. R. Squibb & Sons, Inc. (Princeton, NJ) ➤ Sign Up
Ergonovine ➤ Sign Up Enzymatic hydrolysis of glycidate esters in the presence of bisulfite anion Sepracor, Inc. (Marlborough, MA) ➤ Sign Up
Ergonovine ➤ Sign Up 2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide synthase Abbott Laboratories (Abbott Park, IL) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ergonovine

Drugname Country Document Number Estimated Expiration Related US Patent
Ergonovine Austria 116131 2005-05-01 ➤ Sign Up
Ergonovine Austria 129148 2005-05-01 ➤ Sign Up
Ergonovine Austria 138562 2005-05-01 ➤ Sign Up
Ergonovine Austria 149362 2005-05-01 ➤ Sign Up
Ergonovine Austria 177007 2005-05-01 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Covington
US Department of Justice
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.